Trial Profile
An observational trial to assess valganciclovir in male patients co-infected with HIV and cytomegalovirus that were antiretroviral-naive.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2014
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Pharmacodynamics
- 01 Oct 2014 New trial record